Is a Prostate Biopsy Safe? Risks and Precautions

Prostate biopsy is broadly safe, but it is not risk-free. The most common complications are bleeding and infection, with hospitalization rates that have historically ranged from about 1% to over 6% depending on the technique used and the era of the data. The good news is that the field has shifted dramatically in recent years, and newer approaches have slashed complication rates to levels that would have seemed unrealistic a decade ago. Understanding what those risks actually look like, and what steps reduce them, gives you real leverage over the experience.

How Often Do Complications Require Hospitalization

The headline number most people want is simple: what are the chances something goes seriously wrong? The answer depends heavily on which biopsy technique is used. For the traditional transrectal approach, where the needle passes through the rectal wall, hospital admission rates within 30 days have climbed over time. A large study of over 41,000 men without cancer found the 30-day admission rate rose from 1% in the mid-1990s to about 4% by 2005, with roughly seven out of ten of those admissions caused by infection.¹ A smaller study of 83 patients reported a 3.6% hospitalization rate, with sepsis and heavy rectal bleeding as the culprits.²

Those numbers have prompted a major shift. Danish national registry data show that as transperineal biopsy (where the needle enters through the skin between the scrotum and the anus, avoiding the rectum entirely) replaced the transrectal route, post-biopsy hospitalizations dropped from about 6.5% to 1.1%. Transperineal biopsy use jumped from essentially zero to 87% of all biopsies over just a few years, and the adjusted odds of hospitalization were about 83% lower with the transperineal approach.³ If your urologist offers a transperineal biopsy, the risk profile is meaningfully better than what older statistics describe.

Infection and Sepsis

Infection is the complication that keeps urologists up at night, because it can escalate quickly into sepsis. With transrectal biopsy, the needle punctures the rectal wall, which inevitably drags gut bacteria into the prostate and surrounding tissue. Antibiotic prophylaxis is supposed to prevent this, but rising drug resistance has made that harder. One tertiary-care center study found a urosepsis rate of about 9% following transrectal biopsy, which is at the alarming end of published figures.⁴ Not every center sees numbers that high, but even a few percent is serious when the infection involved can land you in the ICU.

The PREVENT randomized trial compared transperineal and transrectal biopsy head-to-head and found zero infections in the transperineal group versus about 1.6% with transrectal biopsy.⁵ A large study of in-office transperineal biopsies performed under local anesthesia and without antibiotic prophylaxis reported no infections at all in over 500 patients followed for 30 days.⁶ That finding is striking because it suggests that when you avoid the rectal route, the infection risk becomes so low that prophylactic antibiotics may not even be necessary, though practice on this point still varies.

Fluoroquinolone Resistance and Smarter Antibiotic Strategies

The main reason transrectal biopsy infection rates have crept upward is antibiotic resistance. Fluoroquinolones like ciprofloxacin have traditionally been the standard prophylactic antibiotic, but resistant gut bacteria are now common. Rectal swab studies have found fluoroquinolone-resistant organisms in roughly one in five men screened before biopsy.⁷ For those men, standard ciprofloxacin prophylaxis does not cover the bacteria most likely to cause trouble, and infection and hospitalization rates jump considerably. One study of over 2,600 men found that those with fluoroquinolone-resistant bacteria on rectal culture were roughly four times more likely to develop a post-biopsy infection and nearly five times more likely to be hospitalized, compared to men without resistant organisms.⁸

Several strategies have emerged to combat this. One is targeted prophylaxis: a rectal swab is taken before the biopsy, cultured for resistant bacteria, and the antibiotic is chosen based on what the culture shows. In a randomized multicenter trial, culture-based prophylaxis cut infection risk roughly in half compared to empirical treatment.⁹ A smaller randomized study found the difference even starker: 2% infection rate with targeted antibiotics versus 10% with empirical prophylaxis, with all six infections caused by fluoroquinolone-resistant bacteria.¹⁰

Another approach is augmenting or replacing fluoroquinolones. Adding gentamicin to ciprofloxacin reduced sepsis from about 4% to 0% in one study.¹¹ Fosfomycin and trimethoprim/sulfamethoxazole have also been studied as alternatives. A multicenter comparison of all three prophylactic agents found infection rates of about 3%, 3%, and 1% respectively, with no statistically significant differences and no fatal complications or ICU admissions in any group.¹² The overall trend is clear: fluoroquinolone monotherapy is losing its edge in regions with high resistance, and clinicians now have viable alternatives.¹³

Bleeding After Biopsy

Some bleeding is almost guaranteed. The prostate has a rich blood supply, and any needle passing through it will nick blood vessels. The bleeding shows up in three places: urine, stool, and semen. Blood in the semen is the most common and most persistent. A prospective study found that 90% of men who could ejaculate after a transrectal biopsy had blood-tinged semen, lasting an average of about four weeks.¹⁴ It is harmless but understandably alarming if you are not expecting it.

Rectal bleeding after a transrectal biopsy is also common, though usually mild. One study that performed proctoscopy on all patients immediately after biopsy found that nearly half had bleeding significant enough to need compression or another intervention to stop, but the vast majority of those cases resolved with simple pressure. Only about 1.5% of patients needed suturing.¹⁵ Transperineal biopsy sidesteps rectal bleeding entirely, since the needle never touches the rectum, though blood in the urine and semen still occurs.

Urinary Retention

Some men find they cannot urinate after a biopsy, a condition called acute urinary retention. Swelling in the prostate from the needle passes can temporarily squeeze the urethra shut. The risk is not trivial, especially with larger prostates. In a study of transperineal biopsies, about 14% of men experienced retention within 24 hours. The single biggest predictor was prostate size: men whose prostates were above roughly 58 cc were far more likely to need a catheter than those with smaller glands. The number of biopsy cores also mattered, with retention becoming more likely when more than about 23 cores were taken.¹⁶

A larger study of over 750 transperineal biopsies found a lower overall retention rate of about 5.5%, but confirmed that prostate volume above roughly 61 cc tripled the risk. That study also found a link between retention and infection, with men who developed one being significantly more likely to develop the other.¹⁷ If you have an enlarged prostate, your doctor should discuss this risk with you beforehand. The retention is usually temporary and resolves with catheterization, but it means an unpleasant extra step and sometimes an overnight stay.

Blood Thinners and Medication Adjustments

If you take anticoagulants or antiplatelet drugs, the question of whether to stop them before biopsy is more nuanced than you might expect. Guidelines generally recommend that aspirin does not need to be stopped, but other antiplatelet agents should typically be paused or switched to aspirin. Anticoagulants like warfarin are usually replaced with short-acting heparin, though the specifics depend on why you are taking the medication and what your cardiologist advises. Patients on multiple blood-thinning agents may need to delay the biopsy entirely if safe anticoagulation bridging is not feasible.¹⁸

The evidence on aspirin specifically is a bit muddled. One study found a slightly increased bleeding risk with low-dose aspirin but no increased risk from warfarin, concluding that neither drug necessarily needs to be stopped for biopsies of up to ten cores.¹⁹ This is one of those areas where the decision is genuinely individualized. The risk of stopping a blood thinner (stroke, heart attack) may outweigh the risk of extra bleeding from the biopsy, and that calculus is different for every patient. Make sure your urologist and the doctor who prescribes your blood thinner are communicating.

Who Is at Higher Risk for Complications

Certain patient profiles carry a meaningfully elevated risk of post-biopsy infection. A population-based registry study identified diabetes, recent antibiotic treatment for a urinary tract infection, prior fluoroquinolone use, and a positive urine culture as risk factors, each roughly doubling the odds of infection.²⁰ A separate analysis confirmed that a history of urinary infections or prostatitis, a high comorbidity burden, and recent antibiotic use were the most powerful predictors for infectious complications, and that targeted prophylaxis based on rectal culture was especially beneficial in these high-risk men.²¹

If you fall into any of these categories, it is worth raising the topic proactively with your urologist. A transperineal approach, culture-guided antibiotics, or both can substantially reduce your risk compared to a standard transrectal biopsy with empirical ciprofloxacin.

Does Biopsy Affect Erectile Function

Fear of erectile dysfunction after prostate biopsy is common, but the evidence is reassuring. A prospective study that measured erectile function scores before and after transrectal biopsy found essentially no change. Average scores on a validated erectile function questionnaire were statistically identical before and after the procedure.²² Some men do report temporary erectile difficulty in the days following the procedure, but this is thought to be related to anxiety and discomfort rather than any physical damage to the nerves or blood vessels that control erections. The biopsy needle does not reach the neurovascular bundles that run along the outside of the prostate.

Pain Management During the Procedure

Prostate biopsy is uncomfortable, but modern pain control makes it tolerable for most men. The standard technique for transrectal biopsy is a periprostatic nerve block, where local anesthetic is injected around the prostate before sampling begins. A prospective study confirmed that this approach is simple, inexpensive, and effective, with no patient in the nerve block group reporting more than moderate pain.²³ Adding an oral pain reliever like tramadol as a supplement to the nerve block can provide extra comfort without significant safety trade-offs.²⁴

Transperineal biopsy under local anesthesia is also well tolerated. In a study of over 500 in-office transperineal biopsies, about 62% of patients reported only mild pain, and fewer than 3% reported severe pain. No procedures needed to be interrupted.⁶ An earlier feasibility study of 50 patients found that 80% experienced only mild pain.²⁵ Some centers still perform transperineal biopsies under general or spinal anesthesia, but the trend is clearly toward local anesthesia in an office setting, which avoids the added risks and costs of sedation.

Can a Pre-Biopsy MRI Reduce Your Risk

The biggest risk reduction may come before a single needle is inserted. Multiparametric MRI has become the standard for evaluating the prostate before biopsy. It identifies suspicious areas that can be specifically targeted, and just as importantly, it can show when a biopsy is unlikely to be necessary at all. Landmark trials have confirmed that MRI-guided biopsy improves detection of significant cancers while reducing unnecessary biopsies.²⁶ Fewer unnecessary biopsies means fewer men exposed to complications for no clinical benefit. If your urologist recommends a biopsy based on PSA alone without first getting an MRI, it is reasonable to ask whether imaging could clarify the picture first.

The Anxiety Factor

One underappreciated dimension of biopsy safety is psychological. Studies suggest that roughly half of men experience significant anxiety related to the procedure, driven by fear of the biopsy itself and fear of what the results might show. As many as one in five men report anxiety severe enough to warrant medication.²⁷ This is not just an emotional nuisance. Higher anxiety levels have been linked to greater pain during the procedure, longer procedure times, and lower satisfaction with the experience. Knowing what to expect, having a clear conversation with your doctor about pain control, and understanding the actual statistical risk of serious complications can all help. Some men find that the anticipation is considerably worse than the reality.

In-Office Transperineal Biopsy Without Antibiotics

One of the more interesting recent developments is the growing practice of performing transperineal biopsies in a regular office, under local anesthesia, without any antibiotic prophylaxis. Because the needle path avoids the gut entirely, the theoretical infection risk is close to zero, and accumulating data supports that theory. A study of over 500 patients who underwent in-office transperineal biopsy without antibiotics reported no infections at all within 30 days, with an overall complication rate of just 1.1%, nearly all of which were temporary urinary retention.⁶ Another early-experience study using a dedicated access device similarly reported no infectious complications in an office setting without antibiotics.²⁸

Eliminating prophylactic antibiotics matters beyond the individual patient. Every unnecessary antibiotic course contributes to resistance at the population level. If transperineal biopsy can safely be done without antibiotics, it addresses the very drug-resistance problem that has made transrectal biopsy infections harder to prevent. Not every center has adopted this approach yet, and some urologists still give a single prophylactic dose out of caution, but the evidence is building that it may be unnecessary when the perineal route is used.